Drugs & Side Effects | COX-2 / Arthritis

Bextra News

More risks for Cox-2 Inhibitors such as Bextra

RSS News Feeds
Drugs & Pharmacuticals
Bextra
Stevens Johnson Syndrome
Stroke
Heart Attacks
Arthritis Care
 All RSS Feeds

At a glance:

According to a recent New Zeland medical report, the Cox-2 Inhibitor Celebrex poses greater risks than imagined, increasing heart attackes by a multiple of 2.26 times.
 
Even more interesting is the fact that report further supports the fact that the class of medications, Cox II inhibitors, may be the culprit-- a family of medication to which Bextra belongs.
 
Professor Beasley says, of Celebrex, "drug regulatory authorities need to urgently re-examine the assessment of the drug."

Study finds Celebrex doubles heart attack risk

Pharma Times - 3/1/2006 6:07 AM

New Zealand researchers have published a meta-analysis suggesting that Pfizer's COX-2 inhibitor Celebrex doubles the risk of a heart attack.
 
The authors said the results, published in the Journal of the Royal Society of Medicine (March 2006), suggest that the increased risk of cardiovascular side effects that led to the withdrawal of Merck & Co's similar drug Vioxx (rofecoxib) may be
 
· Read The Full Bextra Article From Pharma Times -->

· Read All Bextra (Valdecoxib) News Stories -->

Comments On Bextra News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: